Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 4:01 PM
Ignite Modification Date:
2025-12-26 @ 4:01 PM
NCT ID:
NCT02314806
Eligibility Criteria:
Inclusion Criteria:
* diagnosis of breast neoplasms
* plans to undergo an elective ALND of Berg's levels I and II due to axillary metastasis determined preoperatively by core biopsy or evidence of metastasis in the SLNB in the intraoperative or in the differed analysis.
Exclusion Criteria:
* allergy to any of the antibiotic drugs used
* chronic renal failure due to possible toxicity of gentamicin
* patients undergoing a modified radical mastectomy.
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT02314806
Study Brief:
Protocol Section:
NCT02314806